Altered membrane integrity in the progression of muscle diseases

Life Sciences

Volumn 192, Issue , 2018, Pages 166-172

  McElhanon, Kevin E ^a   Bhattacharya, Sayak ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Dysferlin; Dystrophin; Heart failure; Membrane integrity; Membrane repair; Muscular dystrophy; TRIM72 MG53

Indexed keywords

CALCIUM ION; DYSTROPHIN;

APOPTOSIS; CARDIAC MUSCLE; CARDIOMYOPATHY; CELL DEATH; CELL REGENERATION; DISEASE ASSOCIATION; DISEASE COURSE; GENE; GENE EXPRESSION; HUMAN; MG53 GENE; MUSCLE DISEASE; MUSCLE FIBER MEMBRANE; MUSCLE STRENGTH; MUTATION; MYOPATHY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SARCOLEMMA; SKELETAL MUSCLE; UPREGULATION; ANIMAL; CARDIAC MUSCLE CELL; MEMBRANE; PATHOLOGY;

ANIMALS; HUMANS; MEMBRANES; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOCARDIUM; MYOCYTES, CARDIAC; SARCOLEMMA;

EID: 85037100112     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2017.11.035     Document Type: Review

References (119)

1. Lombard, J., Once upon a time the cell membranes: 175 years of cell boundary research. Biol. Direct, 9, 2014, 32, 10.1186/s13062-014-0032-7.
2. Korn, E.D., Structure and function of the plasma membrane: a biochemical perspective. J. Gen. Physiol. 52 (1968), 257–278.
3. Campbell, K.P., Stull, J.T., Skeletal muscle basement membrane-sarcolemma-cytoskeleton interaction minireview series. J. Biol. Chem. 278 (2003), 12599–12600, 10.1074/jbc.R300005200.
4. Sanes, J.R., The basement membrane/basal lamina of skeletal muscle. J. Biol. Chem. 278 (2003), 12601–12604, 10.1074/jbc.R200027200.
5. Goldstein, J.A., McNally, E.M., Mechanisms of muscle weakness in muscular dystrophy. J. Gen. Physiol. 136 (2010), 29–34, 10.1085/jgp.201010436.
6. Alloush, J., Weisleder, N., TRIM proteins in therapeutic membrane repair of muscular dystrophy. JAMA Neurol. 70 (2013), 928–931, 10.1001/jamaneurol.2013.469.
7. Alloush, J., Roof, S.R., Beck, E.X., Ziolo, M.T., Weisleder, N., Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice. Indian J. Biochem. Biophys. 50 (2013), 428–435.
8. McNeil, P.L., Terasaki, M., Coping with the inevitable: how cells repair a torn surface membrane. Nat. Cell Biol. 3 (2001), E124–129, 10.1038/35074652.
9. McNeil, P.L., Steinhardt, R.A., Loss, restoration, and maintenance of plasma membrane integrity. J. Cell Biol. 137 (1997), 1–4.
10. Rahimov, F., Kunkel, L.M., The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J. Cell Biol. 201 (2013), 499–510, 10.1083/jcb.201212142.
11. Cooper, S.T., Head, S.I., Membrane injury and repair in the muscular dystrophies. Neuroscientist 21 (2015), 653–668, 10.1177/1073858414558336.
12. Weisleder, N. et al., Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci. Transl. Med., 4, 2012 (139ra185) https://doi.org/10.1126/scitranslmed.3003921.
13. Lammerding, J., Lee, R.T., Torn apart: membrane rupture in muscular dystrophies and associated cardiomyopathies. J. Clin. Invest. 117 (2007), 1749–1752, 10.1172/JCI32686.
14. Andrews, N.W., Almeida, P.E., Corrotte, M., Damage control: cellular mechanisms of plasma membrane repair. Trends Cell Biol. 24 (2014), 734–742, 10.1016/j.tcb.2014.07.008.
15. Cooper, S.T., McNeil, P.L., Membrane repair: mechanisms and pathophysiology. Physiol. Rev. 95 (2015), 1205–1240, 10.1152/physrev.00037.2014.
16. Mellgren, R.L. et al., Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases. Biochim. Biophys. Acta 1793 (2009), 1886–1893, 10.1016/j.bbamcr.2009.09.013.
17. Mellgren, R.L., Zhang, W., Miyake, K., McNeil, P.L., Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane. J. Biol. Chem. 282 (2007), 2567–2575, 10.1074/jbc.M604560200.
18. Miyake, K., McNeil, P.L., Vesicle accumulation and exocytosis at sites of plasma membrane disruption. J. Cell Biol. 131 (1995), 1737–1745.
19. Lin, P. et al., Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J. 26 (2012), 1875–1883, 10.1096/fj.11-188599.
20. Weisleder, N., Takeshima, H., Ma, J., Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair. Commun. Integr. Biol. 2 (2009), 225–226.
21. Weisleder, N. et al., Visualization of MG53-mediated cell membrane repair using in vivo and in vitro systems. J. Vis. Exp., 2011, 10.3791/2717.
22. Blazek, A.D., Paleo, B.J., Weisleder, N., Plasma membrane repair: a central process for maintaining cellular homeostasis. Physiology 30 (2015), 438–448, 10.1152/physiol.00019.2015.
23. Jimenez, A.J. et al., ESCRT machinery is required for plasma membrane repair. Science, 343, 2014, 1247136, 10.1126/science.1247136.
24. Cai, C. et al., MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol. 11 (2009), 56–64, 10.1038/ncb1812.
25. Jaiswal, J.K. et al., S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat. Commun., 5, 2014, 3795, 10.1038/ncomms4795.
26. Swaggart, K.A. et al., Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 6004–6009, 10.1073/pnas.1324242111.
27. Lauritzen, S.P., Boye, T.L., Nylandsted, J., Annexins are instrumental for efficient plasma membrane repair in cancer cells. Semin. Cell Dev. Biol. 45 (2015), 32–38, 10.1016/j.semcdb.2015.10.028.
28. Codding, S.J., Marty, N., Abdullah, N., Johnson, C.P., Dysferlin binds SNAREs (soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors) and stimulates membrane fusion in a calcium-sensitive manner. J. Biol. Chem. 291 (2016), 14575–14584, 10.1074/jbc.M116.727016.
29. McNeil, P.L., Kirchhausen, T., An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6 (2005), 499–505, 10.1038/nrm1665.
30. Lennon, N.J. et al., Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem. 278 (2003), 50466–50473, 10.1074/jbc.M307247200.
31. Togo, T., Krasieva, T.B., Steinhardt, R.A., A decrease in membrane tension precedes successful cell-membrane repair. Mol. Biol. Cell 11 (2000), 4339–4346.
32. Duann, P. et al., MG53-mediated cell membrane repair protects against acute kidney injury. Sci. Transl. Med., 7, 2015 (279ra236) https://doi.org/10.1126/scitranslmed.3010755.
33. Tan, T., Ko, Y.G., Ma, J., Dual function of MG53 in membrane repair and insulin signaling. BMB Rep. 49 (2016), 414–423.
34. Bansal, D. et al., Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423 (2003), 168–172, 10.1038/nature01573.
35. Muscular Dystrophy: Hope Through Research | National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Muscular-Dystrophy-Hope-Through-Research#3171_3files/532/Muscular-Dystrophy-Hope-Through-Research.html.
36. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., Sweeney, H.L., Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 3710–3714.
37. Straub, V., Campbell, K.P., Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10 (1997), 168–175.
38. Côté, P.D., Moukhles, H., Lindenbaum, M., Carbonetto, S., Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23 (1999), 338–342, 10.1038/15519.
39. Menke, A., Jockusch, H., Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J. Cell Sci. 108 (1995), 727–733.
40. Muntoni, F., Torelli, S., Ferlini, A., Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2 (2003), 731–740.
41. Kinali, M. et al., Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 76 (2011), 346–353, 10.1212/WNL.0b013e318208811f.
42. Finsterer, J., Stöllberger, C., Cardiac involvement in Becker muscular dystrophy. Can. J. Cardiol. 24 (2008), 786–792.
43. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G., Campbell, K.P., Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345 (1990), 315–319, 10.1038/345315a0.
44. Ibraghimov-Beskrovnaya, O. et al., Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum. Mol. Genet. 2 (1993), 1651–1657.
45. Ibraghimov-Beskrovnaya, O. et al., Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992), 696–702, 10.1038/355696a0.
46. Lim, L.E. et al., β–Sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12. Nat. Genet. 11 (1995), 257–265, 10.1038/ng1195-257.
47. Matsumura, K., Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Campbell, K.P., Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360 (1992), 588–591, 10.1038/360588a0.
48. Yamamoto, H., Hagiwara, Y., Mizuno, Y., Yoshida, M., Ozawa, E., Heterogeneity of dystrophin-associated proteins. J. Biochem. 114 (1993), 132–139.
49. Yoshida, M., Ozawa, E., Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 108 (1990), 748–752.
50. Suzuki, A., Yoshida, M., Yamamoto, H., Ozawa, E., Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 308 (1992), 154–160.
51. Hara, Y. et al., A dystroglycan mutation associated with limb-girdle muscular dystrophy. N. Engl. J. Med. 364 (2011), 939–946, 10.1056/NEJMoa1006939.
52. OMIM Entry - * 128239 - DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1. https://www.omim.org/entry/128239files/714/128239.html.
53. Jimenez-Mallebrera, C., Brown, S.C., Sewry, C.A., Muntoni, F., Congenital muscular dystrophy: molecular and cellular aspects. Cell. Mol. Life Sci. 62 (2005), 809–823, 10.1007/s00018-004-4510-4.
54. Yang, H. et al., Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation. J. Hum. Genet. 61 (2016), 753–759, 10.1038/jhg.2016.42.
55. Lommel, M. et al., Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies. Neurology 74 (2010), 157–164, 10.1212/WNL.0b013e3181c919d6.
56. Longman, C. et al., Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 12 (2003), 2853–2861, 10.1093/hmg/ddg307.
57. Lommel, M., Willer, T., Strahl, S., POMT2, a key enzyme in Walker-Warburg syndrome: somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo. Glycobiology 18 (2008), 615–625, 10.1093/glycob/cwn042.
58. Bönnemann, C.G. et al., Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat. Genet. 11 (1995), 266–273, 10.1038/ng1195-266.
59. Nigro, V. et al., Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14 (1996), 195–198, 10.1038/ng1096-195.
60. Noguchi, S. et al., Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (New York, N.Y.) 270 (1995), 819–822.
61. Hack, A.A. et al., Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J. Cell Sci. 113:Pt 14 (2000), 2535–2544.
62. Campbell, K.P., Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80 (1995), 675–679.
63. Duggan, D.J., Gorospe, J.R., Fanin, M., Hoffman, E.P., Angelini, C., Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med. 336 (1997), 618–624, 10.1056/NEJM199702273360904.
64. Homburger, F., Baker, J.R., Nixon, C.W., Whitney, R., Primary, generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters. PHA 6 (1962), 339–345, 10.1159/000135178.
65. Nigro, V. et al., Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6 (1997), 601–607, 10.1093/hmg/6.4.601.
66. Homburger, F., Baker, J.R., Nixon, C.W., Wilgram, G., Harrop, J., The early histopathological lesion of muscular dystrophy in the Syrian golden hamster. J. Pathol. 89 (1965), 133–138, 10.1002/path.1700890114.
67. Hack, A.A. et al., γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol. 142 (1998), 1279–1287.
68. Bashir, R. et al., A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat. Genet. 20 (1998), 37–42, 10.1038/1689.
69. Liu, J. et al., Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 20 (1998), 31–36, 10.1038/1682.
70. Nigro, V., Savarese, M., Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol. 33 (2014), 1–12.
71. Patel, N.J., Van Dyke, K.W., Espinoza, L.R., Limb-girdle muscular dystrophy 2B and Miyoshi presentations of dysferlinopathy. Am J Med Sci 353 (2017), 484–491, 10.1016/j.amjms.2016.05.024.
72. Achanzar, W.E., Ward, S., A nematode gene required for sperm vesicle fusion. J. Cell Sci. 110:Pt 9 (1997), 1073–1081.
73. Anderson, L.V. et al., Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 8 (1999), 855–861.
74. Matsuda, C. et al., The C2A domain in dysferlin is important for association with MG53 (TRIM72). PLOS Currents, 4, 2012 (e5035add5038caff5034) https://doi.org/10.1371/5035add8caff4.
75. Cai, C. et al., Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J. Biol. Chem. 284 (2009), 15894–15902, 10.1074/jbc.M109.009589.
76. Burr, A.R., Molkentin, J.D., Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy. Cell Death Differ. 22 (2015), 1402–1412, 10.1038/cdd.2015.65.
77. Zhivotovsky, B., Orrenius, S., Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 50 (2011), 211–221, 10.1016/j.ceca.2011.03.003.
78. Spencer, M.J., Croall, D.E., Tidball, J.G., Calpains are activated in necrotic fibers from mdx dystrophic mice. J. Biol. Chem. 270 (1995), 10909–10914, 10.1074/jbc.270.18.10909.
79. Whitehead, N.P., Yeung, E.W., Allen, D.G., Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol. 33 (2006), 657–662, 10.1111/j.1440-1681.2006.04394.x.
80. Gailly, P., De Backer, F., Van Schoor, M., Gillis, J.M., In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice. J. Physiol. 582 (2007), 1261–1275, 10.1113/jphysiol.2007.132191.
81. Spencer, M.J., Mellgren, R.L., Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum. Mol. Genet. 11 (2002), 2645–2655.
82. Haworth, R.A., Hunter, D.R., The Ca2 +-induced membrane transition in mitochondria. Arch. Biochem. Biophys. 195 (1979), 460–467, 10.1016/0003-9861(79)90372-2.
83. Strauss, M., Hofhaus, G., Schröder, R.R., Kühlbrandt, W., Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J. 27 (2008), 1154–1160, 10.1038/emboj.2008.35.
84. Giorgio, V. et al., Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5887–5892, 10.1073/pnas.1217823110.
85. Azarashvili, T. et al., Potential role of subunit c of F0F1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening. Cell Calcium 55 (2014), 69–77, 10.1016/j.ceca.2013.12.002.
86. Alavian, K.N. et al., An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. PNAS 111 (2014), 10580–10585, 10.1073/pnas.1401591111.
87. Nakagawa, T. et al., Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005), 652–658, 10.1038/nature03317.
88. Giorgio, V. et al., Cyclophilin D modulates mitochondrial Fof1 Atp synthase by interacting with the lateral stalk of the complex. J. Biol. Chem., 2009, 10.1074/jbc.M109.020115.
89. Millay, D.P. et al., Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 19023–19028, 10.1073/pnas.0906591106.
90. Bodensteiner, J.B., Engel, A.G., Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28 (1978), 439–446.
91. Bakker, A.J., Head, S.I., Williams, D.A., Stephenson, D.G., Ca2 + levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J. Physiol. 460 (1993), 1–13.
92. Kalogeris, T., Baines, C.P., Krenz, M., Korthuis, R.J., Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 298 (2012), 229–317, 10.1016/B978-0-12-394309-5.00006-7.
93. Charlagorla, P., Liu, J., Patel, M., Rushbrook, J.I., Zhang, M., Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion. Mol. Immunol. 56 (2013), 507–512, 10.1016/j.molimm.2013.05.001.
94. Konstantinidis, K., Whelan, R.S., Kitsis, R.N., Mechanisms of cell death in heart disease. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 1552–1562, 10.1161/ATVBAHA.111.224915.
95. Howard, A.C., McNeil, A.K., McNeil, P.L., Promotion of plasma membrane repair by vitamin E. Nat. Commun., 2, 2011, 597, 10.1038/ncomms1594.
96. Duan, X., Chan, K.T., Lee, K.K., Mak, A.F., Oxidative stress and plasma membrane repair in single myoblasts after femtosecond laser photoporation. Ann. Biomed. Eng. 43 (2015), 2735–2744, 10.1007/s10439-015-1341-4.
97. Sun, Y., Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc. Res. 81 (2009), 482–490, 10.1093/cvr/cvn333.
98. Giordano, F.J., Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115 (2005), 500–508, 10.1172/JCI24408.
99. Li, X. et al., Quantitative profiling of the rat heart myoblast secretome reveals differential responses to hypoxia and re-oxygenation stress. J. Proteome 98 (2014), 138–149, 10.1016/j.jprot.2013.12.025.
100. Han, R., Campbell, K.P., Dysferlin and muscle membrane repair. Curr. Opin. Cell Biol. 19 (2007), 409–416, 10.1016/j.ceb.2007.07.001.
101. Han, R. et al., Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J. Clin. Invest. 117 (2007), 1805–1813, 10.1172/JCI30848.
102. Wallace, G.Q., McNally, E.M., Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu. Rev. Physiol. 71 (2009), 37–57, 10.1146/annurev.physiol.010908.163216.
103. Lenhart, K.C. et al., GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice. Skelet. Muscle, 5, 2015, 27, 10.1186/s13395-015-0054-6.
104. Kaprielian, R.R., Severs, N.J., Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart. Heart Fail. Rev. 5 (2000), 221–238, 10.1023/A:1009805419285.
105. Campbell, M.D., Witcher, M., Gopal, A., Michele, D.E., Dilated cardiomyopathy mutations in delta-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability. Am. J. Physiol. Heart Circ. Physiol. 310 (2016), H1140–1150, 10.1152/ajpheart.00521.2015.
106. Yue, Y., Skimming, J.W., Liu, M., Strawn, T., Duan, D., Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum. Mol. Genet. 13 (2004), 1669–1675, 10.1093/hmg/ddh174.
107. Yasuda, S. et al., Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 436 (2005), 1025–1029, 10.1038/nature03844.
108. He, B. et al., Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in delta-Sarcoglycan-deficient hamsters. Mol. Ther. 20 (2012), 727–735, 10.1038/mt.2012.5.
109. Foo, R.S., Mani, K., Kitsis, R.N., Death begets failure in the heart. J. Clin. Invest. 115 (2005), 565–571, 10.1172/JCI24569.
110. Zhu, H. et al., Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein. Muscle Nerve 52 (2015), 852–858, 10.1002/mus.24619.
111. Cao, C.M. et al., MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121 (2010), 2565–2574, 10.1161/CIRCULATIONAHA.110.954628.
112. Wang, X. et al., Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ. Res. 107 (2010), 76–83, 10.1161/CIRCRESAHA.109.215822.
113. Becker, L.B., New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004), 461–470, 10.1016/j.cardiores.2003.10.025.
114. Kohr, M.J., Evangelista, A.M., Ferlito, M., Steenbergen, C., Murphy, E., S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. J. Mol. Cell. Cardiol. 69 (2014), 67–74, 10.1016/j.yjmcc.2014.01.010.
115. Zhang, Y., Wu, H.K., Lv, F., Xiao, R.P., MG53: biological function and potential as a therapeutic target. Mol. Pharmacol. 92 (2017), 211–218, 10.1124/mol.117.108241.
116. Zhang, Y. et al., MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc. Res. 91 (2011), 108–115, 10.1093/cvr/cvr029.
117. Yi, J.S. et al., MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat. Commun., 4, 2013, 2354, 10.1038/ncomms3354.
118. Liu, J. et al., Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. J. Mol. Cell. Cardiol. 80 (2015), 10–19, 10.1016/j.yjmcc.2014.12.010.
119. Ichikawa, Y. et al., Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits. PLoS One, 12, 2017, e0177660, 10.1371/journal.pone.0177660.